| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR DLG5 MAP1A SPTAN1 SPTBN1 SPTBN2 NUMA1 VPS16 PSTPIP2 MAST2 MEFV STARD9 KIF4B GNB1 KIF17 NLRP5 | 9.60e-05 | 1099 | 99 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | dynein complex binding | 3.54e-04 | 28 | 99 | 3 | GO:0070840 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 6.12e-04 | 78 | 99 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 6.68e-04 | 8 | 99 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 6.74e-04 | 80 | 99 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.07e-03 | 10 | 99 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 1.07e-03 | 10 | 99 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | helicase activity | 1.14e-03 | 158 | 99 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B SMARCA4 ZNF888 ZNF525 ZNF761 ZNF468 ZNF160 MGA | 1.17e-03 | 1244 | 99 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | S-methyltransferase activity | 1.30e-03 | 11 | 99 | 2 | GO:0008172 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.30e-03 | 428 | 99 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B SMARCA4 ZNF888 ZNF525 ZNF761 ZNF468 ZNF160 MGA | 1.45e-03 | 1271 | 99 | 15 | GO:0000987 |
| GeneOntologyMolecularFunction | cadherin binding | 1.50e-03 | 339 | 99 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 1.74e-03 | 48 | 99 | 3 | GO:0032266 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 2.07e-03 | 51 | 99 | 3 | GO:0003743 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | TPR SPTBN1 NUMA1 LATS1 APPL2 CCNB2 ZNF655 CRLF3 EIF4E SNX18 SMARCA4 LRP5 KIF4B MAD2L1 PCNT | 1.34e-05 | 854 | 99 | 15 | GO:1903047 |
| GeneOntologyCellularComponent | spectrin | 8.74e-06 | 9 | 100 | 3 | GO:0008091 | |
| Domain | Spectrin/alpha-actinin | 7.14e-07 | 32 | 100 | 5 | IPR018159 | |
| Domain | SPEC | 7.14e-07 | 32 | 100 | 5 | SM00150 | |
| Domain | Spectrin | 6.34e-06 | 23 | 100 | 4 | PF00435 | |
| Domain | P-loop_NTPase | DLG5 DIRAS1 SPEF2 LRRK1 NLRP14 DDX50 STARD9 EIF4A1 SMARCA4 KIF4B CARD11 DDX53 GNAL KIF17 DHX29 NLRP5 | 1.07e-05 | 848 | 100 | 16 | IPR027417 |
| Domain | Spectrin_repeat | 1.66e-05 | 29 | 100 | 4 | IPR002017 | |
| Domain | MeTrfase_trithorax | 2.84e-05 | 2 | 100 | 2 | IPR016569 | |
| Domain | DUF3498 | 8.48e-05 | 3 | 100 | 2 | IPR021887 | |
| Domain | DUF3498 | 8.48e-05 | 3 | 100 | 2 | PF12004 | |
| Domain | PH | 1.24e-04 | 278 | 100 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 1.27e-04 | 279 | 100 | 8 | PS50003 | |
| Domain | KRAB | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF761 ZNF468 ZNF160 | 1.30e-04 | 358 | 100 | 9 | PS50805 |
| Domain | KRAB | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF761 ZNF468 ZNF160 | 1.30e-04 | 358 | 100 | 9 | PF01352 |
| Domain | PH_domain | 1.30e-04 | 280 | 100 | 8 | IPR001849 | |
| Domain | - | 1.42e-04 | 93 | 100 | 5 | 1.10.533.10 | |
| Domain | KRAB | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF761 ZNF468 ZNF160 | 1.63e-04 | 369 | 100 | 9 | SM00349 |
| Domain | ZF_PHD_1 | 1.65e-04 | 96 | 100 | 5 | PS01359 | |
| Domain | KRAB | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF761 ZNF468 ZNF160 | 1.66e-04 | 370 | 100 | 9 | IPR001909 |
| Domain | FAM47 | 1.69e-04 | 4 | 100 | 2 | PF14642 | |
| Domain | FAM47 | 1.69e-04 | 4 | 100 | 2 | IPR032743 | |
| Domain | Spectrin_bsu | 1.69e-04 | 4 | 100 | 2 | IPR016343 | |
| Domain | DEATH-like_dom | 1.91e-04 | 99 | 100 | 5 | IPR011029 | |
| Domain | DAPIN | 2.13e-04 | 22 | 100 | 3 | PS50824 | |
| Domain | PYRIN | 2.13e-04 | 22 | 100 | 3 | PF02758 | |
| Domain | DAPIN | 2.13e-04 | 22 | 100 | 3 | IPR004020 | |
| Domain | PYRIN | 2.13e-04 | 22 | 100 | 3 | SM01289 | |
| Domain | PH | 2.31e-04 | 229 | 100 | 7 | PF00169 | |
| Domain | Helicase_C | 2.75e-04 | 107 | 100 | 5 | PF00271 | |
| Domain | HELICc | 2.75e-04 | 107 | 100 | 5 | SM00490 | |
| Domain | FYrich_C | 2.81e-04 | 5 | 100 | 2 | IPR003889 | |
| Domain | FYrich_N | 2.81e-04 | 5 | 100 | 2 | IPR003888 | |
| Domain | FYRC | 2.81e-04 | 5 | 100 | 2 | SM00542 | |
| Domain | FYRN | 2.81e-04 | 5 | 100 | 2 | SM00541 | |
| Domain | FYRN | 2.81e-04 | 5 | 100 | 2 | PF05964 | |
| Domain | FYRC | 2.81e-04 | 5 | 100 | 2 | PF05965 | |
| Domain | FYRC | 2.81e-04 | 5 | 100 | 2 | PS51543 | |
| Domain | FYRN | 2.81e-04 | 5 | 100 | 2 | PS51542 | |
| Domain | Helicase_C | 2.87e-04 | 108 | 100 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 2.99e-04 | 109 | 100 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.99e-04 | 109 | 100 | 5 | PS51192 | |
| Domain | DEXDc | 2.99e-04 | 109 | 100 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.12e-04 | 110 | 100 | 5 | IPR014001 | |
| Domain | zf-C2H2 | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF525 ZNF761 ZNF468 ZNF160 | 3.28e-04 | 693 | 100 | 12 | PF00096 |
| Domain | - | DLG5 DIRAS1 SPEF2 LRRK1 NLRP14 DDX50 EIF4A1 SMARCA4 CARD11 DDX53 GNAL DHX29 | 6.33e-04 | 746 | 100 | 12 | 3.40.50.300 |
| Domain | DEAD/DEAH_box_helicase_dom | 6.34e-04 | 73 | 100 | 4 | IPR011545 | |
| Domain | DEAD | 6.34e-04 | 73 | 100 | 4 | PF00270 | |
| Domain | PHD | 7.03e-04 | 75 | 100 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 8.55e-04 | 79 | 100 | 4 | IPR019787 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF525 ZNF761 ZNF468 ZNF160 | 8.83e-04 | 775 | 100 | 12 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF525 ZNF761 ZNF468 ZNF160 | 9.03e-04 | 777 | 100 | 12 | PS00028 |
| Domain | PH_dom-spectrin-type | 9.97e-04 | 9 | 100 | 2 | IPR001605 | |
| Domain | Q_MOTIF | 1.01e-03 | 37 | 100 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 1.01e-03 | 37 | 100 | 3 | IPR014014 | |
| Domain | - | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF761 ZNF468 ZNF160 | 1.02e-03 | 679 | 100 | 11 | 3.30.160.60 |
| Domain | Znf_FYVE_PHD | 1.17e-03 | 147 | 100 | 5 | IPR011011 | |
| Domain | - | 1.20e-03 | 391 | 100 | 8 | 2.30.29.30 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF761 ZNF468 ZNF160 | 1.21e-03 | 694 | 100 | 11 | IPR013087 |
| Domain | Znf_C2H2 | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF525 ZNF761 ZNF468 ZNF160 | 1.22e-03 | 805 | 100 | 12 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF525 ZNF761 ZNF468 ZNF160 | 1.26e-03 | 808 | 100 | 12 | SM00355 |
| Domain | PHD | 1.33e-03 | 89 | 100 | 4 | SM00249 | |
| Domain | Kinesin_motor_CS | 1.37e-03 | 41 | 100 | 3 | IPR019821 | |
| Domain | Znf_PHD | 1.45e-03 | 91 | 100 | 4 | IPR001965 | |
| Domain | zf-C2H2_6 | 1.50e-03 | 314 | 100 | 7 | PF13912 | |
| Domain | Znf_CXXC | 1.51e-03 | 11 | 100 | 2 | IPR002857 | |
| Domain | ZF_CXXC | 1.51e-03 | 11 | 100 | 2 | PS51058 | |
| Domain | zf-CXXC | 1.51e-03 | 11 | 100 | 2 | PF02008 | |
| Domain | KINESIN_MOTOR_1 | 1.68e-03 | 44 | 100 | 3 | PS00411 | |
| Domain | - | 1.68e-03 | 44 | 100 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.68e-03 | 44 | 100 | 3 | IPR001752 | |
| Domain | Kinesin | 1.68e-03 | 44 | 100 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.68e-03 | 44 | 100 | 3 | PS50067 | |
| Domain | KISc | 1.68e-03 | 44 | 100 | 3 | SM00129 | |
| Domain | ZF_PHD_2 | 1.70e-03 | 95 | 100 | 4 | PS50016 | |
| Domain | PH_dom-like | 2.05e-03 | 426 | 100 | 8 | IPR011993 | |
| Domain | RasGAP | 2.48e-03 | 14 | 100 | 2 | SM00323 | |
| Domain | Ldl_recept_b | 2.48e-03 | 14 | 100 | 2 | PF00058 | |
| Domain | LDLRB | 2.48e-03 | 14 | 100 | 2 | PS51120 | |
| Domain | RasGAP_CS | 2.48e-03 | 14 | 100 | 2 | IPR023152 | |
| Domain | START | 2.85e-03 | 15 | 100 | 2 | PF01852 | |
| Domain | RasGAP | 2.85e-03 | 15 | 100 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.85e-03 | 15 | 100 | 2 | PS00509 | |
| Domain | START_lipid-bd_dom | 2.85e-03 | 15 | 100 | 2 | IPR002913 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.85e-03 | 15 | 100 | 2 | PS50018 | |
| Domain | START | 2.85e-03 | 15 | 100 | 2 | PS50848 | |
| Domain | LY | 2.85e-03 | 15 | 100 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.85e-03 | 15 | 100 | 2 | IPR000033 | |
| Domain | Post-SET_dom | 3.24e-03 | 16 | 100 | 2 | IPR003616 | |
| Domain | PostSET | 3.24e-03 | 16 | 100 | 2 | SM00508 | |
| Domain | - | 3.24e-03 | 16 | 100 | 2 | 1.10.506.10 | |
| Domain | POST_SET | 3.24e-03 | 16 | 100 | 2 | PS50868 | |
| Domain | Leu-rich_rpt | 3.37e-03 | 271 | 100 | 6 | IPR001611 | |
| Domain | Znf_C2H2-like | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF761 ZNF468 ZNF160 | 3.53e-03 | 796 | 100 | 11 | IPR015880 |
| Domain | RasGAP_dom | 4.11e-03 | 18 | 100 | 2 | IPR001936 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.56e-05 | 10 | 73 | 3 | MM15112 | |
| Pubmed | DAB2IP TPR SESTD1 TRIO DOCK11 SPTAN1 SPTBN1 SPTBN2 HECTD4 NUMA1 SEC31A SYNGAP1 EIF4A1 STRN4 SMARCA4 CCAR2 KIF4B GNB1 MGA SPATA13 PCNT | 9.13e-13 | 963 | 104 | 21 | 28671696 | |
| Pubmed | SMIM24 STARD13 SPEF2 SPTAN1 SPTBN1 CNTRL SPTBN2 NUMA1 FAM47B LATS1 DDX50 PHF20L1 STARD9 EIF4A1 STRN4 KMT2A CCAR2 GNB1 SPATA13 PCNT | 9.10e-09 | 1442 | 104 | 20 | 35575683 | |
| Pubmed | SESTD1 RAP1GDS1 TRIO SPTAN1 SPTBN1 SPTBN2 HECTD4 SEC31A LRP1B FAN1 SYNGAP1 APPL2 GRHPR ZNF655 EIF4A1 SMARCA4 GNB1 PCNT | 4.80e-08 | 1285 | 104 | 18 | 35914814 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.81e-07 | 281 | 104 | 9 | 28706196 | |
| Pubmed | TPR RAP1GDS1 MAP1A SPTAN1 SPTBN1 CNTRL SPTBN2 SEC31A LATS1 MGA GAREM1 | 2.46e-07 | 486 | 104 | 11 | 20936779 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 TRIO CNTRL SPTBN2 MAST2 LRP1B LATS1 CCNB2 EIF4E SNX18 POC5 GNB1 MGA PCNT | 2.65e-07 | 853 | 104 | 14 | 28718761 |
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 5.16e-07 | 6 | 104 | 3 | 37069398 | |
| Pubmed | DAB2IP TRIO CDKN2AIP SPTAN1 SPTBN1 SPTBN2 PSTPIP2 FAN1 DDX50 CCNB2 CRLF3 CCAR2 POC5 MAD2L1 PCNT | 5.49e-07 | 1049 | 104 | 15 | 27880917 | |
| Pubmed | TPR SPTAN1 SPTBN1 SPTBN2 NUMA1 FRYL ZCCHC3 EIF4A1 SMARCA4 KMT2A CCAR2 PCNT | 6.23e-07 | 653 | 104 | 12 | 22586326 | |
| Pubmed | TPR KMT2B SPTAN1 SPTBN2 ATG2B NUMA1 LATS1 STRN4 SMARCA4 KMT2A MGA | 8.15e-07 | 549 | 104 | 11 | 38280479 | |
| Pubmed | 9.06e-07 | 250 | 104 | 8 | 33536335 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP NDOR1 KMT2B DIRAS1 TRIO HECTD4 FRYL LRRK1 MAST2 NAPRT STRN4 LRP5 SPATA13 GAREM1 PCNT | 1.05e-06 | 1105 | 104 | 15 | 35748872 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPR SPTAN1 SPTBN1 SPTBN2 NUMA1 VPS16 EIF4A1 SMARCA4 LRP5 CCAR2 GNB1 DHX29 PCNT | 1.54e-06 | 847 | 104 | 13 | 35235311 |
| Pubmed | 1.55e-06 | 118 | 104 | 6 | 30979931 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR CDKN2AIP NUMA1 PHF20L1 CCNB2 EIF4A1 EIF4E STRN4 SMARCA4 CCAR2 KIF4B POC5 GNAL GNB1 MAD2L1 | 1.81e-06 | 1155 | 104 | 15 | 20360068 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 TRIO DOCK11 SPTAN1 SPTBN1 FRYL MAST2 BMPR2 LATS1 STARD9 ZNF286B KMT2A SPATA13 | 1.84e-06 | 861 | 104 | 13 | 36931259 |
| Pubmed | 2.34e-06 | 284 | 104 | 8 | 29459677 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 3.07e-06 | 10 | 104 | 3 | 22159418 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 4.21e-06 | 11 | 104 | 3 | 17607528 | |
| Pubmed | 6.23e-06 | 86 | 104 | 5 | 37253089 | ||
| Pubmed | TPR CDKN2AIP SPTAN1 SPTBN1 SPTBN2 FRYL ZCCHC3 EIF4A1 CCAR2 MGA | 6.33e-06 | 551 | 104 | 10 | 34728620 | |
| Pubmed | 7.27e-06 | 13 | 104 | 3 | 18796539 | ||
| Pubmed | 7.27e-06 | 13 | 104 | 3 | 24619213 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.37e-06 | 332 | 104 | 8 | 32786267 | |
| Pubmed | KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. | 8.86e-06 | 2 | 104 | 2 | 28723559 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17854671 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32483278 | ||
| Pubmed | Characterization of a new beta-spectrin gene which is predominantly expressed in brain. | 8.86e-06 | 2 | 104 | 2 | 9675416 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 14978793 | ||
| Pubmed | Identification of a mouse brain beta-spectrin cDNA and distribution of its mRNA in adult tissues. | 8.86e-06 | 2 | 104 | 2 | 1742606 | |
| Pubmed | Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase. | 8.86e-06 | 2 | 104 | 2 | 25320244 | |
| Pubmed | AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner. | 8.86e-06 | 2 | 104 | 2 | 16061630 | |
| Pubmed | Spectrin-actin interaction is required for neurite extension in NB 2a/dl neuroblastoma cells. | 8.86e-06 | 2 | 104 | 2 | 8776664 | |
| Pubmed | Mad2 promotes Cyclin B2 recruitment to the kinetochore for guiding accurate mitotic checkpoint. | 8.86e-06 | 2 | 104 | 2 | 35384228 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8406479 | ||
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 8.86e-06 | 2 | 104 | 2 | 26884715 | |
| Pubmed | Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E. | 8.86e-06 | 2 | 104 | 2 | 27879264 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26814130 | ||
| Pubmed | 1.10e-05 | 251 | 104 | 7 | 27507650 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 TPR SPTAN1 SPTBN1 NUMA1 OAS3 SEC31A VPS16 DDX50 GRHPR EIF4A1 SMARCA4 CCAR2 MGA DHX29 | 1.21e-05 | 1353 | 104 | 15 | 29467282 |
| Pubmed | 1.71e-05 | 17 | 104 | 3 | 21628590 | ||
| Pubmed | 1.71e-05 | 17 | 104 | 3 | 20479123 | ||
| Pubmed | 1.82e-05 | 181 | 104 | 6 | 37372979 | ||
| Pubmed | 1.91e-05 | 497 | 104 | 9 | 23414517 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 2.05e-05 | 18 | 104 | 3 | 12119179 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR KMT2B KDM5C SPTAN1 SPTBN1 NUMA1 LATS1 SMARCA4 KMT2A CCAR2 DHX29 | 2.11e-05 | 774 | 104 | 11 | 15302935 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR TRIO SPTAN1 SPTBN1 NUMA1 SEC31A MAST2 DDX50 STARD9 EIF4A1 EIF4E SMARCA4 CCAR2 GNB1 DHX29 | 2.22e-05 | 1425 | 104 | 15 | 30948266 |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 15590904 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 30744688 | ||
| Pubmed | NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis. | 2.65e-05 | 3 | 104 | 2 | 27889185 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18981471 | ||
| Pubmed | Spindle assembly checkpoint robustness requires Tpr-mediated regulation of Mad1/Mad2 proteostasis. | 2.65e-05 | 3 | 104 | 2 | 24344181 | |
| Pubmed | Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. | 2.65e-05 | 3 | 104 | 2 | 10880459 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 35331081 | ||
| Pubmed | LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. | 2.65e-05 | 3 | 104 | 2 | 27166870 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24362264 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 8479293 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10576550 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18195096 | ||
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 2.65e-05 | 3 | 104 | 2 | 1467942 | |
| Pubmed | alpha -Catenin binds directly to spectrin and facilitates spectrin-membrane assembly in vivo. | 2.65e-05 | 3 | 104 | 2 | 11069925 | |
| Pubmed | 2.76e-05 | 399 | 104 | 8 | 37536630 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.15e-05 | 120 | 104 | 5 | 31413325 | |
| Pubmed | Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. | 3.32e-05 | 21 | 104 | 3 | 12202484 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 3.32e-05 | 21 | 104 | 3 | 27626377 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.97e-05 | 208 | 104 | 6 | 33230847 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.68e-05 | 430 | 104 | 8 | 35044719 | |
| Pubmed | The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A. | 5.29e-05 | 4 | 104 | 2 | 8449919 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 8521827 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 23826075 | ||
| Pubmed | Spatiotemporal control of mitosis by the conserved spindle matrix protein Megator. | 5.29e-05 | 4 | 104 | 2 | 19273613 | |
| Pubmed | Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts. | 5.29e-05 | 4 | 104 | 2 | 29176883 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 5.29e-05 | 4 | 104 | 2 | 3862089 | |
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 5.29e-05 | 4 | 104 | 2 | 23129768 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 17166833 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 21412925 | ||
| Pubmed | Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA. | 5.29e-05 | 4 | 104 | 2 | 34156981 | |
| Pubmed | WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket. | 5.29e-05 | 4 | 104 | 2 | 18840606 | |
| Pubmed | Eukaryotic initiation factors 4A (eIF4A) and 4G (eIF4G) mutually interact in a 1:1 ratio in vivo. | 5.29e-05 | 4 | 104 | 2 | 11408474 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 26267306 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 17088250 | ||
| Pubmed | MLL1 is required for PAX7 expression and satellite cell self-renewal in mice. | 5.29e-05 | 4 | 104 | 2 | 31534153 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 9372926 | ||
| Pubmed | Brain beta spectrin isoform 235 (Spnb-2) maps to mouse chromosome 11. | 5.29e-05 | 4 | 104 | 2 | 1638088 | |
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 5.29e-05 | 4 | 104 | 2 | 24064296 | |
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 5.29e-05 | 4 | 104 | 2 | 12820899 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 25834037 | ||
| Pubmed | BMP1-like proteinases are essential to the structure and wound healing of skin. | 5.29e-05 | 4 | 104 | 2 | 27363389 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 5.34e-05 | 134 | 104 | 5 | 25452129 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 5.69e-05 | 25 | 104 | 3 | 30309841 | |
| Pubmed | 6.04e-05 | 446 | 104 | 8 | 24255178 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF765 ZNF845 SPTBN1 ZNF813 SYNGAP1 ZNF320 ZNF28 ZNF655 ZNF525 ZNF468 ZNF160 MGA MAD2L1 | 6.30e-05 | 1203 | 104 | 13 | 29180619 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1A DOCK11 SPTAN1 SEC31A PSTPIP2 ZCCHC3 EIF4E SNX18 MGA DHX29 | 6.46e-05 | 724 | 104 | 10 | 36232890 |
| Pubmed | 6.52e-05 | 332 | 104 | 7 | 37433992 | ||
| Pubmed | 8.28e-05 | 147 | 104 | 5 | 16959763 | ||
| Pubmed | 8.59e-05 | 347 | 104 | 7 | 17114649 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 26320581 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 25561738 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 16648488 | ||
| Interaction | KALRN interactions | 1.50e-09 | 96 | 103 | 9 | int:KALRN | |
| Interaction | TRIM28 interactions | ZNF765 ZNF845 MAP1A KDM5C SPTAN1 NUMA1 ZNF813 SEC31A VPS16 ZNF320 ZNF28 GRHPR ZNF544 ZNF655 EIF4A1 SMARCA4 ZNF888 CCAR2 ZNF761 ZNF468 GNB1 UHRF2 ZNF160 DHX29 | 2.92e-07 | 1474 | 103 | 24 | int:TRIM28 |
| Interaction | YWHAE interactions | DAB2IP SESTD1 DLG5 RAP1GDS1 DOCK11 SPTAN1 FRYL MAST2 FAN1 SYNGAP1 LATS1 APPL2 GRHPR KMT2A CCAR2 GNB1 MGA EFCAB7 SPATA13 GAREM1 | 4.83e-06 | 1256 | 103 | 20 | int:YWHAE |
| Interaction | PRECSIT interactions | 1.07e-05 | 9 | 103 | 3 | int:PRECSIT | |
| Interaction | YWHAH interactions | DAB2IP DLG5 TRIO DOCK11 SPTAN1 SPTBN1 CNTRL HECTD4 FRYL MAST2 SYNGAP1 LATS1 STARD9 ZNF286B KMT2A CCAR2 SPATA13 PCNT | 1.10e-05 | 1102 | 103 | 18 | int:YWHAH |
| Interaction | AGAP2 interactions | 1.24e-05 | 210 | 103 | 8 | int:AGAP2 | |
| Interaction | CNKSR2 interactions | 2.21e-05 | 66 | 103 | 5 | int:CNKSR2 | |
| Interaction | TNIK interactions | TPR TRIO DOCK11 SPTAN1 SPTBN1 SPTBN2 SYNGAP1 STRN4 CCAR2 MGA | 2.57e-05 | 381 | 103 | 10 | int:TNIK |
| Interaction | SYNGAP1 interactions | 2.82e-05 | 307 | 103 | 9 | int:SYNGAP1 | |
| Interaction | PCNT interactions | 3.33e-05 | 241 | 103 | 8 | int:PCNT | |
| Interaction | YWHAZ interactions | DAB2IP SESTD1 DLG5 DOCK11 SPTAN1 SPTBN1 SPTBN2 HECTD4 FRYL MAST2 FAN1 SYNGAP1 LATS1 STARD9 KMT2A CCAR2 SPATA13 GAREM1 PCNT | 3.51e-05 | 1319 | 103 | 19 | int:YWHAZ |
| Interaction | DLGAP1 interactions | 3.89e-05 | 180 | 103 | 7 | int:DLGAP1 | |
| Interaction | DISC1 interactions | 6.96e-05 | 429 | 103 | 10 | int:DISC1 | |
| Interaction | KAT8 interactions | 1.27e-04 | 95 | 103 | 5 | int:KAT8 | |
| Interaction | KCNA3 interactions | TPR DLG5 SPEF2 SPTBN1 ATG2B NUMA1 SEC31A LATS1 EIF4A1 SMARCA4 KMT2A CARD11 DHX29 NLRP5 | 1.38e-04 | 871 | 103 | 14 | int:KCNA3 |
| Interaction | PURG interactions | 1.49e-04 | 223 | 103 | 7 | int:PURG | |
| Cytoband | 19q13.42 | 4.40e-07 | 125 | 104 | 6 | 19q13.42 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF765 ZNF845 KMT2B ZNF813 ZNF320 ZNF28 ZNF544 STRN4 ZNF888 ZNF525 ZNF761 ZNF468 ZNF160 NLRP5 | 5.32e-07 | 1192 | 104 | 14 | chr19q13 |
| Cytoband | 19q13.41 | 3.12e-05 | 78 | 104 | 4 | 19q13.41 | |
| Cytoband | 8q24.22 | 6.76e-04 | 17 | 104 | 2 | 8q24.22 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.76e-06 | 7 | 68 | 3 | 1113 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF765 ZNF845 ZNF813 ZNF320 ZNF28 ZNF544 ZNF655 ZNF286B ZNF888 ZNF525 ZNF761 ZNF468 ZNF160 | 2.29e-06 | 718 | 68 | 13 | 28 |
| GeneFamily | PHD finger proteins | 2.22e-05 | 90 | 68 | 5 | 88 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.10e-04 | 25 | 68 | 3 | 994 | |
| GeneFamily | DEAD-box helicases | 5.26e-04 | 42 | 68 | 3 | 499 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 6.15e-04 | 10 | 68 | 2 | 830 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.88e-04 | 46 | 68 | 3 | 622 | |
| GeneFamily | Zinc fingers CXXC-type | 8.98e-04 | 12 | 68 | 2 | 136 | |
| GeneFamily | Low density lipoprotein receptors | 1.06e-03 | 13 | 68 | 2 | 634 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.07e-03 | 206 | 68 | 5 | 682 | |
| GeneFamily | StAR related lipid transfer domain containing | 1.42e-03 | 15 | 68 | 2 | 759 | |
| GeneFamily | NLR family | 3.95e-03 | 25 | 68 | 2 | 666 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.27e-03 | 26 | 68 | 2 | 904 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.24e-03 | 34 | 68 | 2 | 487 | |
| GeneFamily | Tudor domain containing | 8.53e-03 | 37 | 68 | 2 | 780 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.14e-06 | 199 | 102 | 8 | M5893 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 1.36e-05 | 200 | 102 | 7 | M331 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.37e-08 | 200 | 104 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.56e-07 | 200 | 104 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 178 | 104 | 6 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 4.69e-06 | 184 | 104 | 6 | c294cd421f277992b56ae9c40b8f3948e33148fe | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 5.15e-06 | 187 | 104 | 6 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-06 | 194 | 104 | 6 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-06 | 196 | 104 | 6 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.77e-05 | 28 | 104 | 3 | 456cf2e0a6ea59c279efc77a1d02e5572196cb6b | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 170 | 104 | 5 | db0ec8b7ecbb4db108fc35c564df4b740f65cc8f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 170 | 104 | 5 | 88f6804e973863245ca1c7e5e6656d4a8b824da9 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 4.94e-05 | 170 | 104 | 5 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 170 | 104 | 5 | dad3aaf7d9f7bafdbddee51610f03f2359e587ae | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 175 | 104 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 175 | 104 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.98e-05 | 177 | 104 | 5 | e36c2005be74ee8ff03c2052504cb496faf86009 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 180 | 104 | 5 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 180 | 104 | 5 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.82e-05 | 182 | 104 | 5 | 6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.00e-05 | 183 | 104 | 5 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 7.37e-05 | 185 | 104 | 5 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 7.75e-05 | 187 | 104 | 5 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 7.75e-05 | 187 | 104 | 5 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.15e-05 | 189 | 104 | 5 | 31d34bc75d4457fca197e1766922e987dbd5f8a9 | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 8.35e-05 | 190 | 104 | 5 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 8.35e-05 | 190 | 104 | 5 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.35e-05 | 190 | 104 | 5 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.35e-05 | 190 | 104 | 5 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 8.56e-05 | 191 | 104 | 5 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.99e-05 | 193 | 104 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.99e-05 | 193 | 104 | 5 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.44e-05 | 195 | 104 | 5 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 195 | 104 | 5 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.44e-05 | 195 | 104 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.67e-05 | 196 | 104 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 9.67e-05 | 196 | 104 | 5 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-05 | 197 | 104 | 5 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.90e-05 | 197 | 104 | 5 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.01e-04 | 198 | 104 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-04 | 200 | 104 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A | 3.34e-06 | 200 | 102 | 8 | 1592_DN | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 6.66e-05 | 4 | 99 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | myocardial infarction | 1.82e-04 | 350 | 99 | 7 | EFO_0000612 | |
| Disease | Writer's Cramp | 2.31e-04 | 7 | 99 | 2 | C4316810 | |
| Disease | Dystonia Disorders | 2.31e-04 | 7 | 99 | 2 | C0393593 | |
| Disease | Idiopathic familial dystonia | 2.31e-04 | 7 | 99 | 2 | C0393598 | |
| Disease | Adult-Onset Idiopathic Focal Dystonias | 2.31e-04 | 7 | 99 | 2 | C0752198 | |
| Disease | Adult-Onset Dystonias | 2.31e-04 | 7 | 99 | 2 | C0752197 | |
| Disease | Adult-Onset Idiopathic Torsion Dystonias | 2.31e-04 | 7 | 99 | 2 | C0752199 | |
| Disease | Autosomal Dominant Familial Dystonia | 2.31e-04 | 7 | 99 | 2 | C0752200 | |
| Disease | Childhood Onset Dystonias | 2.31e-04 | 7 | 99 | 2 | C0752202 | |
| Disease | Autosomal Recessive Familial Dystonia | 2.31e-04 | 7 | 99 | 2 | C0752201 | |
| Disease | Dystonia, Primary | 2.31e-04 | 7 | 99 | 2 | C0752203 | |
| Disease | Dystonias, Sporadic | 2.31e-04 | 7 | 99 | 2 | C0752206 | |
| Disease | Dystonia, Secondary | 2.31e-04 | 7 | 99 | 2 | C0752205 | |
| Disease | Pseudodystonia | 2.31e-04 | 7 | 99 | 2 | C0752208 | |
| Disease | Familial Dystonia | 2.31e-04 | 7 | 99 | 2 | C0752207 | |
| Disease | Focal Dystonia | 2.31e-04 | 7 | 99 | 2 | C0743332 | |
| Disease | Developmental delay (disorder) | 2.62e-04 | 37 | 99 | 3 | C0424605 | |
| Disease | vascular endothelial function measurement | 3.52e-04 | 99 | 99 | 4 | EFO_0803369 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 6.83e-04 | 118 | 99 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | alcohol consumption measurement, alcohol drinking | 7.20e-04 | 12 | 99 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | Papillary Renal Cell Carcinoma | 9.25e-04 | 128 | 99 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 9.25e-04 | 128 | 99 | 4 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 9.25e-04 | 128 | 99 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 9.25e-04 | 128 | 99 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 9.25e-04 | 128 | 99 | 4 | C1266044 | |
| Disease | periodontitis | 9.47e-04 | 223 | 99 | 5 | EFO_0000649 | |
| Disease | dystonia (is_implicated_in) | 9.88e-04 | 14 | 99 | 2 | DOID:543 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 9.88e-04 | 14 | 99 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.30e-03 | 16 | 99 | 2 | EFO_0008297 | |
| Disease | myopia (is_implicated_in) | 1.30e-03 | 16 | 99 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Dystonia, Limb | 1.47e-03 | 17 | 99 | 2 | C0751093 | |
| Disease | esophageal carcinoma, gastric carcinoma | 1.47e-03 | 17 | 99 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | Dystonia, Diurnal | 1.47e-03 | 17 | 99 | 2 | C0393610 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.47e-03 | 17 | 99 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | factor XI measurement, Ischemic stroke | 1.47e-03 | 17 | 99 | 2 | EFO_0004694, HP_0002140 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.58e-03 | 148 | 99 | 4 | C0279702 | |
| Disease | Myeloid Leukemia | 1.65e-03 | 18 | 99 | 2 | C0023470 | |
| Disease | Dystonia, Paroxysmal | 1.65e-03 | 18 | 99 | 2 | C0393588 | |
| Disease | Leukemia, Monocytic, Chronic | 1.65e-03 | 18 | 99 | 2 | C0023466 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.83e-03 | 154 | 99 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 1.84e-03 | 19 | 99 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 1.84e-03 | 19 | 99 | 2 | C2936783 | |
| Disease | prostate cancer (is_marker_for) | 1.92e-03 | 156 | 99 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Schizophrenia | 2.90e-03 | 883 | 99 | 9 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEKEAWRLLAQEEAA | 381 | Q8N6Y0 | |
| LEEWEALCQQKAAEA | 436 | Q8N163 | |
| EEDCFKALIWIRNNS | 816 | Q8NHU2 | |
| LQEEERWCESLEKTL | 2006 | Q7Z7A1 | |
| VFEAVLNWAEAECKR | 301 | Q96KE9 | |
| EDLLLNEWEASKCNI | 611 | Q7Z478 | |
| WDINKRGVEETAAEC | 66 | Q7Z5P4 | |
| LDKWCLNEILESADA | 51 | Q96BY7 | |
| NKAEECETWIDRFRK | 466 | Q8N0U7 | |
| VREEWQSEHIKACEA | 201 | Q9H939 | |
| DIFKLAEANACWALE | 836 | Q7RTW8 | |
| RELKEVFASWRQECS | 491 | Q5VWQ8 | |
| WKDVVERACQARAEE | 296 | Q8NA72 | |
| RHDIDCQWIDITDVK | 671 | P58215 | |
| RDEKNEVIATVLCWD | 566 | Q8WZ60 | |
| WCDARTDKIERIDLE | 2056 | Q9NZR2 | |
| KAENEEAAACPAWER | 2376 | P78559 | |
| VLERWQFDIECDKTA | 96 | Q13257 | |
| IEIISDCNWEEDRNK | 1336 | Q8IWI9 | |
| KAERDILAEADNEWV | 751 | O95835 | |
| RGEEVVWCLDDKANS | 1746 | Q38SD2 | |
| VIAKIQEIWCEEDER | 21 | A0A075B734 | |
| LFWVDADLKRIESCD | 1126 | O75197 | |
| DKIAIWTTECENREA | 161 | P06730 | |
| AAWVEALRCDGETDK | 16 | Q9NXV6 | |
| INVEREEWKLDTLCD | 251 | P60842 | |
| IVRWCKVDDDFTAQD | 196 | Q8IUI8 | |
| RAVRDVKTDWNEECK | 341 | Q9H706 | |
| VKREAAEQWLDDCKR | 2791 | O94915 | |
| ERKLEDAWARCEARE | 156 | Q8NA70 | |
| DAWARCEAREKTTEV | 161 | Q8NA70 | |
| EALQEADVAKCRRDW | 511 | Q8TDM6 | |
| EKIKEEWNFVAECRR | 41 | Q9BYS8 | |
| NKVDDAWDLLREATD | 1781 | P24043 | |
| VRVDFKEDCDLENVW | 1171 | Q9UMN6 | |
| RDKTLIEEQWEDFCS | 761 | P59047 | |
| LEAKECQSEWELLQD | 516 | O15553 | |
| KSALAEKVRQCWQDD | 211 | P18054 | |
| AFQVLANRCVEWEKE | 1326 | Q9Y4D8 | |
| LKEDWESEKDLCLEN | 346 | O95613 | |
| EAEWQELEKRDCLTL | 496 | Q9UHB4 | |
| WDDEGVKACFERSNE | 141 | P38405 | |
| DERRKWIQCFNDVTA | 216 | P38405 | |
| DTREAQAVAQEWKCA | 131 | O95057 | |
| WDLNRNVTDIECVKD | 41 | P26951 | |
| KWEDVNAAACDLARE | 86 | Q9H2M3 | |
| AESRRQCNVDIKWVD | 791 | Q5JSL3 | |
| DALLCKIEDIDNEDW | 111 | O95067 | |
| ENLVWSSVEDNCRRK | 1441 | P17927 | |
| DFNCNVWDALKADRA | 291 | P62873 | |
| DEDAWAVCRENFDTK | 441 | A8K855 | |
| VALARAADCEVEQWD | 21 | Q9UBQ7 | |
| LVERLVEWCEAKDHA | 446 | P52306 | |
| LKETIEDCWDQDAEA | 476 | Q13873 | |
| EEIQDVSCAWKELNR | 596 | Q9BQ39 | |
| QAESRKENEEWICAI | 356 | Q8NEU8 | |
| QEIERLEHIDKWCRD | 31 | Q86X45 | |
| LWESECAQAVKEDPA | 1726 | Q6P0Q8 | |
| KHLDPERELEDAWAC | 151 | Q5JRC9 | |
| LLDAESEDRPKQCWE | 841 | Q2VIQ3 | |
| IRVDFKEDCEAENVW | 1401 | Q03164 | |
| SNWDRIRAAVVECEK | 151 | Q86TM3 | |
| KDEEDALWENVECNR | 16 | Q9BXL7 | |
| TAEDLDWEKEAAFQC | 226 | Q3SYA9 | |
| SECEQLVKEVAAWRE | 801 | Q14980 | |
| NARWDLLAKEAAACT | 1051 | Q9Y6K5 | |
| DFKAGEEVLARWTDC | 86 | A8MW92 | |
| NLEKILRESCWDEDN | 876 | Q9P2E2 | |
| EAKELAQCAKRDWNR | 626 | Q9Y2M0 | |
| LWDICDARKEEAEQE | 1116 | Q9C093 | |
| QEIEAKEACDWLRAA | 56 | Q9Y3M8 | |
| WIIKDDAEVERLTCE | 1346 | P51532 | |
| ANRLWCSKARAEDEE | 51 | O75264 | |
| LWKERRALEEQCDED | 621 | Q9P2P6 | |
| KDRCVVAAFWADVDN | 96 | Q8TER0 | |
| KCEEDAAQAVEWLSE | 501 | Q86VW0 | |
| SEADACELWIDEKEQ | 856 | Q01082 | |
| ENEVLEAWKSLLDAC | 1886 | Q01082 | |
| RDVAIEFSQEEWKCL | 11 | Q96IR2 | |
| RDVAIEFSQEEWKCL | 11 | Q8N782 | |
| QEDKARWLQACADER | 546 | Q96N96 | |
| REDCQNQKLWDEVLS | 701 | Q96PU4 | |
| RDVAIEFSQEEWKCL | 11 | Q86XN6 | |
| RDVAIEFSQEEWKCL | 11 | Q9HCG1 | |
| RDVAIEFSQEEWKCL | 11 | A2RRD8 | |
| EKREQEDCWENFVVL | 231 | Q9NUD5 | |
| SAVAWEERFCALEKL | 2061 | O15020 | |
| FACRSAAERDKWIEN | 231 | Q96PV0 | |
| ESQLLECKASWEERE | 1121 | P12270 | |
| RDVDAWVFSLECKLD | 581 | Q96RF0 | |
| EDAVKARLAALADQW | 1626 | Q13813 | |
| DWDLKEELRDCLVAA | 26 | Q9H269 | |
| DLAAKAQVWLEQVCA | 241 | Q6XQN6 | |
| RDVAIEFSQEEWKCL | 11 | Q6ZN06 | |
| RDVAIEFSQEEWKCL | 11 | P0CJ79 | |
| EVLTRQKAFDCDVWE | 456 | Q8N720 | |
| DLCRAEQEAPRDWKA | 71 | Q6NX49 | |
| RDVAIEFSQEEWKCL | 11 | P17035 | |
| RDVAIEFSQEEWKCL | 11 | Q7L2R6 | |
| AQLHCQASEKEEREW | 196 | Q5SQS7 | |
| AEKARWEAERAELQA | 81 | Q9NRL3 | |
| FSKWERQCLAEAEQD | 21 | Q14CZ0 | |
| SNLEAALECENWLEK | 151 | P0CG31 | |
| VESCDLKNWREALAA | 641 | O94979 | |
| RDVAIEFSQEEWKCL | 11 | Q5VIY5 | |
| LEQEWKAFAAALDER | 426 | O75962 | |
| ERWEEKAHLCLEARQ | 981 | P41229 | |
| DLCERAKEEINWSAQ | 86 | Q86W24 |